Mentor, Pharmaceutical Scientist, Cancer Researcher and Professor working to develop nano-medicines and drug therapies. Tweets are my own! #MentorFirst
@AAPSNano AAPS Members can use their account information, non-members can set up an account for free: https://t.co/Hl5IA4bB5U:
Here is the link to join the session: https://t.co/eC44iWGBZq
I am thrilled to announce a 'Three-minute thesis competition' by the AAPS Nano Community! Submit a single ppt with voice over by August 1 to be considered! We look forward to seeing all of the nanotechnology research and recognizing participants at the annual meeting in October!
“EPR effect vs. ATR concept” 🎯
Do nanomedicines accumulate in tumors passively or actively?
Is this different in different tumor types, or for soft vs. hard nanoparticles?
How do new targeting mechanisms contribute to clinical impact?
Check out https://t.co/PdkdmsQqKR
🎉 Exciting news! Our paper on breast cancer mechanobiology is published in Cancer and Metastasis Reviews @springerNature! Special thanks to my student Ayuba, our collaborators @rustyarnold@LAA0917 and funding sources @BCRFAlabama@NIH. Check it out: https://t.co/enf3NhSOj9
Excited to see our latest review published on “Cell and biomaterial delivery strategies to induce immune tolerance.” Congratulations to the whole team that put together this outstanding and comprehensive paper led by first author Brianna @briscotland95! https://t.co/DR69R8kJBn
The American Association of Pharmaceutical Scientists (AAPS) | @aapscomms Nanotechnology community pictured below had its annual community meeting today and continues to go from strength to strength offering educational and career development activities throughout the year.
2023 Marathon #MTBNats are done and dusted. Dry conditions, a fast and twisty course, and strong competition made for some close finishes at Chewacla State Park. Congratulations to all racers bringing home the stars and stripes jersey!
Metronomic administration of topotecan alone and in combination with docetaxel inhibits epithelial-mesenchymal transition in aggressive variant #prostatecancers, by Ghosh et al.
https://t.co/2kaejCbEDS
@AuburnU#openaccess
@AshleyAlready Well unless your target audience is 16 year old boys, if you think they are cute then go with your instinct. Sure some "older" men and women might see them differently.
Interesting article on incentivizing work/play.
The Passion Paradox: We have a deep desire to chase our passions, but by chasing them, we may actually reduce our passion for them.
3 strategies for escaping the paradox from @SahilBloom...https://t.co/cNDX4sHSnx